[1]
Basa-Dénes, O., Angi, R., Kárpáti, B., Jordán, T. and Ötvös, Z. 2021. Nano-amorphous Oral Sirolimus Formulation with Improved Exposure and Low Inter-individual Variability. Acta Pharmaceutica Hungarica. 91, 3-4 (Nov. 2021), 181-183. DOI:https://doi.org/10.33892/aph.2021.91.181-183.